CRAP Regulatory Strategy & Submission Management

Question 1

What is the main purpose of a regulatory strategy?

Accepted Answer

To ensure efficient approval and compliance

Answer

A regulatory strategy outlines the plan for navigating the complex regulatory landscape to bring a product to market. Its main purpose is to ensure that all necessary regulatory requirements are met efficiently, leading to timely approval while maintaining full compliance with relevant laws and guidelines. This minimizes risks and accelerates market access for new products.

Question 2

Which agency approves drug submissions in the United States?

Accepted Answer

FDA

Answer

In the United States, the Food and Drug Administration (FDA) is the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. All new drug submissions must be approved by the FDA before they can be marketed and sold in the U.S.

Question 3

What is a CTD?

Accepted Answer

Common Technical Document

Answer

The Common Technical Document (CTD) is a globally accepted format for organizing applications for new drugs and biologics. Developed by the International Council for Harmonisation (ICH), it standardizes the structure of regulatory submissions, making it easier for regulatory authorities worldwide to review and evaluate product information. This harmonization streamlines the approval process across different regions.

Question 4

Why is early regulatory engagement important?

Accepted Answer

To align with expectations and avoid delays

Answer

Early regulatory engagement involves consulting with regulatory agencies during the initial stages of product development. This proactive approach helps developers understand agency expectations, identify potential regulatory hurdles, and align their development strategy accordingly. By addressing concerns early, companies can avoid costly delays and ensure a smoother, more efficient approval process.

Question 5

What is an IND submission?

Accepted Answer

Investigational New Drug application

Answer

An Investigational New Drug (IND) application is a submission to the FDA that allows a pharmaceutical company to begin clinical trials in humans with a new drug. It provides comprehensive information on the drug's composition, manufacturing, and preclinical (animal) study results, demonstrating that it is reasonably safe for initial human testing. Without an approved IND, clinical trials cannot proceed.

(CRAP) Certified Regulatory Affairs Professional Practice Test

(CRAP) Certified Regulatory Affairs Professional Practice Test

CRAP Regulatory Strategy & Submission Management